FDA Drug Application (083666) for HYDROCHLOROTHIAZIDE W/ RESERPINE by WATSON LABS

Back to FDA Applications sponsored by WATSON LABS

Application Number083666
Product Number001
FormTABLET;ORAL
Dosage50MG;0.125MG
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameHYDROCHLOROTHIAZIDE W/ RESERPINE
Active IngredientHYDROCHLOROTHIAZIDE; RESERPINE

Active IngredientCount
List of drugs with Active Ingredient HYDROCHLOROTHIAZIDE122
List of drugs with Active Ingredient RESERPINE52


Back to FDA Applications sponsored by WATSON LABS